ARCHIVES

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 42 | October 15, 1976

Download PDF Visit The Full Archive

Related Articles

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999

ACC Survey Preliminary Finding: Three Cancer DRG Categories “Clearly Underpaid Across The Board”

January 25, 1985

In Brief: Georgetown, Theurer Form Collaboration; Hopkins To Develop Bladder Cancer Institute

June 6, 2014

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007